However, the BCSS advantage in the TP30 populations and both the RFS and BCSS advantages in the TP50 populations failed to reach statistical significance (Table 3 ).
← all excerpts
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.
1
—
—